openPR Logo
Press release

Unlock Advanced Dabigatran Research with High-Purity Standards: Now Available - Dabigatran 13C6, 3-Aminobenzoyl Impurity, Desamino Pyridine Chloro Impurity & Amide Ester Impurity for Enhanced Accuracy, Compliance, and Analytical Excellence

05-30-2025 10:38 AM CET | Chemicals & Materials

Press release from: Aquigen Bio Sciences

Unlock Advanced Dabigatran Research with High-Purity

In the ever-evolving pharmaceutical landscape, precision, safety, and regulatory compliance have never been more crucial. With Dabigatran etexilate mesylate becoming a cornerstone in the management of thromboembolic disorders, the demand for high-purity standards and robust impurity profiling has surged. Recognizing this essential need, a new suite of advanced analytical tools for Dabigatran and its associated impurities has been made available to support the global scientific and quality control community.

To kno about category Dabigatran: https://aquigenbio.com/products/impurity-standards/dabigatran/

Dabigatran 13C6 - Isotope-Labeled Precision for Quantification and Tracing
The introduction of Dabigatran 13C6, a stable isotope-labeled variant of Dabigatran, provides an indispensable resource for pharmacokinetic studies, bioequivalence research, and LC-MS/MS-based quantification. Its isotopic purity and chemical stability make it ideal for use as an internal standard, enabling researchers to track metabolic pathways and ensure high fidelity in bioanalytical methods.

Dabigatran 3-Aminobenzoyl Impurity - Crucial for Regulatory Compliance
The 3-Aminobenzoyl Impurity of Dabigatran is a structurally significant degradation product and synthetic intermediate. Monitoring its presence is vital for maintaining stringent ICH guidelines for impurity profiling and ensuring batch-to-batch consistency in Dabigatran formulation development. Accurate identification and quantification of this impurity support both early-stage R&D and late-stage QC protocols.

Dabigatran Desamino Pyridine Chloro Impurity - Advanced Structural Elucidation
A rarer but analytically challenging compound, the Dabigatran Desamino Pyridine Chloro Impurity, provides insights into structural integrity and forced degradation studies. Its unique chemical structure serves as a valuable reference standard for stress testing and method validation, aiding in the prediction of potential degradation pathways that can affect drug stability over time.

To know more about products:
1. Dabigatran 13C6 https://aquigenbio.com/product/dabigatran-13c6/
2.Dabigatran 3-Aminobenzoyl Impurity https://aquigenbio.com/product/dabigatran-3-aminobenzoyl-impurity/
3.Dabigatran Desamino Pyridine Chloro Impurity
https://aquigenbio.com/product/dabigatran-desamino-pyridine-chloro-impurity/

Dabigatran Amide Ester Impurity - Indicator of Process Efficiency and Purity
A byproduct often encountered during the synthetic pathway of Dabigatran, the Amide Ester Impurity serves as a quality marker for process optimization. Its identification is critical for refining synthetic routes and ensuring the finished API remains within acceptable impurity thresholds. This impurity standard is essential for developing validated analytical methods that safeguard drug purity and efficacy.

Driving Scientific Progress Through Purity and Precision
As regulatory authorities such as the FDA, EMA, and CDSCO continue to emphasize the importance of comprehensive impurity profiling, having access to well-characterized and certified reference standards is no longer optional-it's imperative. These Dabigatran-associated compounds, now available as high-purity analytical standards, offer pharmaceutical researchers, CROs, and quality control laboratories the confidence to meet international quality benchmarks with precision.

To know more about Dabigatran Amide Ester Impurity
https://aquigenbio.com/product/dabigatran-amide-ester-impurity/

With the availability of Dabigatran 13C6, 3-Aminobenzoyl Impurity, Desamino Pyridine Chloro Impurity, and Amide Ester Impurity, scientific institutions and pharma manufacturers are better equipped than ever to ensure safety, efficacy, and compliance throughout the drug development life cycle.

Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com

Aquigen Bio Sciences stands as India's premier resource for high-quality N-Nitroso impurity standards, impelling advancements in pharmaceutical research and manufacturing. Specializing in providing precise impurity standards - including degradation impurities, process impurities, and deuterated isotopes - Aquigen Bio Sciences empowers the industry to comply with the most rigorous global regulations. The contract research organization's commitment to precision and reliability makes it the trusted partner for addressing complex issues like N-Nitroso impurities in pharmaceuticals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Unlock Advanced Dabigatran Research with High-Purity Standards: Now Available - Dabigatran 13C6, 3-Aminobenzoyl Impurity, Desamino Pyridine Chloro Impurity & Amide Ester Impurity for Enhanced Accuracy, Compliance, and Analytical Excellence here

News-ID: 4042966 • Views:

More Releases from Aquigen Bio Sciences

Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control. Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.
Elevating Analytical Precision with Harmine Impurity Standards
Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance. Why Harmine Impurity Standards Matter https://aquigenbio.com/products/impurity-standards/harmine/ Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has
AquigenBio Introduces High-Purity Daridorexant Hydrochloride to Support Sleep Disorder Research and Analytical Development
AquigenBio Introduces High-Purity Daridorexant Hydrochloride to Support Sleep Di …
India - August 2025 - AquigenBio, a premier provider of pharmaceutical reference standards and impurity profiling solutions, proudly announces the release of Daridorexant Hydrochloride (CAS No. 1792993-84-0). This high-quality, precisely characterized compound is a hydrochloride salt form of Daridorexant, a dual orexin receptor antagonist with proven efficacy in the treatment of insomnia. Explore Daridorexant Hydrochloride - https://aquigenbio.com/product/daridorexant-hydrochloride/ The launch of this product marks a significant addition to AquigenBio's growing portfolio of sleep
Riociguat N-Nitroso Des Formyl Impurity - Reliable Reference Standard for Advanced Pharmaceutical Analysis
Riociguat N-Nitroso Des Formyl Impurity - Reliable Reference Standard for Advanc …
Riociguat N-Nitroso Des Formyl Impurity is a premium-quality analytical reference material developed to support research, testing, and quality control in the pharmaceutical industry. As regulatory guidelines tighten worldwide, accurate detection, quantification, and control of nitroso impurities have become an essential part of drug development and manufacturing. This compound plays a vital role in ensuring that formulations containing Riociguat meet the highest safety and compliance standards. The Growing Importance of Nitroso Impurity

All 5 Releases


More Releases for Dabigatran

Dabigatran Market Trends, Key Players, DROT, Analysis & Forecast Till 2032
The Dabigatran market size was valued at USD 0.59 billion in 2023 and is projected to increase from USD 0.66 billion in 2024 to USD 1.62 billion by 2032. The market is anticipated to grow at a compound annual growth rate (CAGR) of approximately 11.8% during the forecast period from 2024 to 2032. Market Trends The Dabigatran market is characterized by several key trends. A significant trend is the increasing preference for
Dabigatran & Dabigatran Generic Drug Market Trends 2022 | Segmentation, Outlook, …
The dabigatran dabigatran generic drugs market is anticipated to grow at a significant CAGR of 8.2% during the forecast period (2022-2028). Dabigartran drug is used in the treatment of DVT. DVT is deep vein thrombosis in which a blood clot is experienced usually in the limb. This drug is also given in the case of pulmonary embolism in which a blood clot develops in the lungs. Pulmonary embolism can appear
Dabigatran & Dabigatran Generic Drugs Market: Competitive Dynamics & Global Outl …
LP INFORMATION recently released a research report on the Dabigatran & Dabigatran Generic Drugs market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Dabigatran & Dabigatran Generic Drugsmarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Dabigatran & Dabigatran Generic
Dabigatran & Dabigatran Generic Drugs Market Size, CAGR Status, Market trends, A …
This report also researches and evaluates the impact of Covid-19 outbreak on the Dabigatran & Dabigatran Generic Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Dabigatran & Dabigatran Generic Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). The recent report added by GLOBAL INFO RESEARCH gives a detailed account of the drivers and restraints in the global Dabigatran &
Dabigatran Etexilate Mesylate Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Dabigatran Etexilate Mesylate Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Dabigatran Etexilate Mesylate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Dabigatran Etexilate Mesylate with respect
Global Dabigatran Market Growth (Status and Outlook) 2019-2024
LP INFORMATION offers a latest published report on Dabigatran Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Dabigatran market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report